BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 17869448)

  • 1. A phase III, double-blind, placebo-controlled prospective randomized clinical trial of d-threo-methylphenidate HCl in brain tumor patients receiving radiation therapy.
    Butler JM; Case LD; Atkins J; Frizzell B; Sanders G; Griffin P; Lesser G; McMullen K; McQuellon R; Naughton M; Rapp S; Stieber V; Shaw EG
    Int J Radiat Oncol Biol Phys; 2007 Dec; 69(5):1496-501. PubMed ID: 17869448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Symptom clusters in patients with newly-diagnosed brain tumors.
    Gleason JF; Case D; Rapp SR; Ip E; Naughton M; Butler JM; McMullen K; Stieber V; Saconn P; Shaw EG
    J Support Oncol; 2007 Oct; 5(9):427-33, 436. PubMed ID: 18019850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patient-controlled methylphenidate for cancer fatigue: a double-blind, randomized, placebo-controlled trial.
    Bruera E; Valero V; Driver L; Shen L; Willey J; Zhang T; Palmer JL
    J Clin Oncol; 2006 May; 24(13):2073-8. PubMed ID: 16648508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of dexmethylphenidate for the treatment of fatigue after cancer chemotherapy: a randomized clinical trial.
    Lower EE; Fleishman S; Cooper A; Zeldis J; Faleck H; Yu Z; Manning D
    J Pain Symptom Manage; 2009 Nov; 38(5):650-62. PubMed ID: 19896571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of OROS methylphenidate in adults with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled, double-blind, parallel group, dose-escalation study.
    Adler LA; Zimmerman B; Starr HL; Silber S; Palumbo J; Orman C; Spencer T
    J Clin Psychopharmacol; 2009 Jun; 29(3):239-47. PubMed ID: 19440077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient-controlled methylphenidate for the management of fatigue in patients with advanced cancer: a preliminary report.
    Bruera E; Driver L; Barnes EA; Willey J; Shen L; Palmer JL; Escalante C
    J Clin Oncol; 2003 Dec; 21(23):4439-43. PubMed ID: 14645434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does methylphenidate reduce the symptoms of chronic fatigue syndrome?
    Blockmans D; Persoons P; Van Houdenhove B; Bobbaers H
    Am J Med; 2006 Feb; 119(2):167.e23-30. PubMed ID: 16443425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparing effects of methylphenidate, sertraline and placebo on neuropsychiatric sequelae in patients with traumatic brain injury.
    Lee H; Kim SW; Kim JM; Shin IS; Yang SJ; Yoon JS
    Hum Psychopharmacol; 2005 Mar; 20(2):97-104. PubMed ID: 15641125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of methylphenidate on fatigue and depression: a randomized, double-blind, placebo-controlled trial.
    Kerr CW; Drake J; Milch RA; Brazeau DA; Skretny JA; Brazeau GA; Donnelly JP
    J Pain Symptom Manage; 2012 Jan; 43(1):68-77. PubMed ID: 22208450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methylphenidate improves fatigue scores in Parkinson disease: a randomized controlled trial.
    Mendonça DA; Menezes K; Jog MS
    Mov Disord; 2007 Oct; 22(14):2070-6. PubMed ID: 17674415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short-term efficacy of methylphenidate: a randomized, double-blind, placebo-controlled trial among survivors of childhood cancer.
    Mulhern RK; Khan RB; Kaplan S; Helton S; Christensen R; Bonner M; Brown R; Xiong X; Wu S; Gururangan S; Reddick WE
    J Clin Oncol; 2004 Dec; 22(23):4795-803. PubMed ID: 15570081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Will improvement in quality of life (QOL) impact fatigue in patients receiving radiation therapy for advanced cancer?
    Brown P; Clark MM; Atherton P; Huschka M; Sloan JA; Gamble G; Girardi J; Frost MH; Piderman K; Rummans TA
    Am J Clin Oncol; 2006 Feb; 29(1):52-8. PubMed ID: 16462503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of methylphenidate and/or levodopa combined with physiotherapy on mood and cognition after stroke: a randomized, double-blind, placebo-controlled trial.
    Delbari A; Salman-Roghani R; Lokk J
    Eur Neurol; 2011; 66(1):7-13. PubMed ID: 21701174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective evaluation of quality of life and neurocognitive effects in patients with multiple brain metastases receiving whole-brain radiotherapy with or without thalidomide on Radiation Therapy Oncology Group (RTOG) trial 0118.
    Corn BW; Moughan J; Knisely JP; Fox SW; Chakravarti A; Yung WK; Curran WJ; Robins HI; Brachman DG; Henderson RH; Mehta MP; Movsas B
    Int J Radiat Oncol Biol Phys; 2008 May; 71(1):71-8. PubMed ID: 18164829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective evaluation of the prevalence and severity of fatigue in patients with prostate cancer undergoing radical external beam radiotherapy and neoadjuvant hormone therapy.
    Truong PT; Berthelet E; Lee JC; Petersen R; Lim JT; Gaul CA; Pai H; Blood P; Ludgate CM
    Can J Urol; 2006 Jun; 13(3):3139-46. PubMed ID: 16813705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Double-blind, randomized trial of dexmethylphenidate hydrochloride for the treatment of sarcoidosis-associated fatigue.
    Lower EE; Harman S; Baughman RP
    Chest; 2008 May; 133(5):1189-95. PubMed ID: 18263672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Donepezil for cancer fatigue: a double-blind, randomized, placebo-controlled trial.
    Bruera E; El Osta B; Valero V; Driver LC; Pei BL; Shen L; Poulter VA; Palmer JL
    J Clin Oncol; 2007 Aug; 25(23):3475-81. PubMed ID: 17687152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methylphenidate for the treatment of apathy in Alzheimer disease: prediction of response using dextroamphetamine challenge.
    Herrmann N; Rothenburg LS; Black SE; Ryan M; Liu BA; Busto UE; Lanctôt KL
    J Clin Psychopharmacol; 2008 Jun; 28(3):296-301. PubMed ID: 18480686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized, placebo-controlled trial of three fixed dosages of prolonged-release OROS methylphenidate in adults with attention-deficit/hyperactivity disorder.
    Medori R; Ramos-Quiroga JA; Casas M; Kooij JJ; Niemelä A; Trott GE; Lee E; Buitelaar JK
    Biol Psychiatry; 2008 May; 63(10):981-9. PubMed ID: 18206857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multivitamins do not improve radiation therapy-related fatigue: results of a double-blind randomized crossover trial.
    de Souza Fêde AB; Bensi CG; Trufelli DC; de Oliveira Campos MP; Pecoroni PG; Ranzatti RP; Kaliks R; Del Giglio A
    Am J Clin Oncol; 2007 Aug; 30(4):432-6. PubMed ID: 17762445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.